Journal
The Journal of Prevention of Alzheimer's Disease
Publication Date
1-1-2022
Volume
9
Issue
3
First Page
393
Last Page
399
Document Type
Open Access Publication
DOI
10.14283/jpad.2022.48
Rights and Permissions
Delrieu, J., Bateman, R.J., Touchon, J. et al. The Future of AD Clinical Trials with the Advent of Anti-Amyloid Therapies: An CTAD Task Force Report. J Prev Alzheimers Dis 9, 393–399 (2022). https://doi.org/10.14283/jpad.2022.48 This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
Recommended Citation
Delrieu, J; Bateman, R J; Touchon, J; Sabbagh, M; and Cummings, J, "The future of AD clinical trials with the advent of anti-amyloid therapies: An CTAD Task Force report." The Journal of Prevention of Alzheimer's Disease. 9, 3. 393 - 399. (2022).
https://digitalcommons.wustl.edu/oa_4/453
